Effect of a traditional preparation rectal suppository from Commiphora mukul (Hook. Ex Stocks) Engl. And Allium porrum L. on hemorrhoids in comparison with conventional anti-hemorrhoid suppository: A double-blind controlled trial
The aim of this study is to evaluate the therapeutic effect of a traditional rectal suppository containing Commiphora mukul (Hook. Ex Stocks) Engl. and Allium porrum L. in hemorrhoid.
Design
A clinical trial with an interventional and a control groups, double-blind, 80 patients, randomization by block randomization method.
Settings and conduct
In this study, patients were recruited at Shahid Rahnamon Hospital in Yazd. The doctor and patients are blinded in the study. The researcher provides the traditional rectal suppository and conventional anti-hemorrhoid suppository to the patient in sealed envelopes with a allocation concealment method, and the color and packaging of the both groups are completely similar.
Participants/Inclusion and exclusion criteria
Patients who suffer from hemorrhoids and dose not require emergency surgery with approval of a surgeon specialist are included in the study. The main exclusion criteria are other anorectal diseases (ex. fistula or anal cancer and perianal fissure), pregnancy and lactation.
Intervention groups
The patients are divided into two groups of 40 people randomly by block randomization method. The Colo-Rectal Evaluation of Clinical Therapeutics
Scale (CORECTS) questionnaire and consent form completed by every patients. the Interventional group is taking a Traditional Rectal suppository and the control group Anti-hemorrhoid suppository. The medication in all two groups is taking a rectal suppository for two weeks, twice a day. After the end of the consumption period, the patient's symptoms are evaluated by the questionnaire.
Main outcome variables
Pain, itching, bleeding and swelling relief are evaluated according to the CORECTS questionnaire.
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20231224060516N1
Registration date:2024-01-23, 1402/11/03
Registration timing:registered_while_recruiting
Last update:2024-01-23, 1402/11/03
Update count:0
Registration date
2024-01-23, 1402/11/03
Registrant information
Name
Motahare Nayebzadeh
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 71 3242 3127
Email address
motaharenayeb@sums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-01-20, 1402/10/30
Expected recruitment end date
2025-01-19, 1403/10/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of a traditional preparation rectal suppository from Commiphora mukul (Hook. Ex Stocks) Engl. And Allium porrum L. on hemorrhoids in comparison with conventional anti-hemorrhoid suppository: A double-blind controlled trial
Public title
Effect of traditional preparation rectal suppository in treatment of hemorrhoids
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Suffering from hemorrhoids based on the diagnosis of a general surgeon that does not require emergency surgery
The patient must sign a consent form and cooperate during the study
Has not been treated for hemorrhoids in the past month
Exclusion criteria:
Fourth-degree hemorrhoids
Pregnancy
Breastfeeding
Diabetes
Portal hypertension
Various known coagulopathy
Liver and kidney failure
Inflammatory bowel diseases
Perianal fissure
Anal fistula
Taking medication for hemorrhoids in the last 1 month
History Hemorrhoid surgery in the last 6 months
Thrombosed external hemorrhoid
Strangulated internal hemorrhoid
Anal abscess
History of perianal surgery
Mucosal prolapse
Cancer and other malignancies
Age
No age limit
Gender
Both
Phase
N/A
Groups that have been masked
Participant
Care provider
Sample size
Target sample size:
80
Randomization (investigator's opinion)
Randomized
Randomization description
The patients are divided into two groups of 40 people randomly by simple block randomization method.
All subjects are made aware of the content of
the study and written informed consent was obtained
from each patient.
Coding and sealing of both suppositories by a non-researcher of the study is done by simple block randomization method and using Random Number Generation software.
During that time the doctor, researcher and patients are not aware of the block numbers.
Common anti-hemorrhoid suppositories are removed from the relevant company's packaging and placed in specially designed boxes for clinical trials, and the labels are removed.
The Colo-Rectal Evaluation of Clinical Therapeutics Scale questionnaire (CORECTS) questionnaire completed by individuals.
The Interventional group is taking a Traditional Rectal suppository and the control group Anti-hemorrhoid suppository. Both groups of people receive the Drugs in the form of sealed envelopes with a allocation concealment method, and it should be noted that the color and packaging of the both groups drugs are completely similar. The medication in all two groups is taking a rectal suppository for two weeks, twice a day. After the end of the consumption period, the patient's symptoms are evaluated by the questionnaire.
The data are collected after 14 days, and then the codes of the drug packages and related questionnaires are opened.
Blinding (investigator's opinion)
Double blinded
Blinding description
The doctor and the patient are blinded in the study. The researcher provides the traditional rectal suppository and conventional anti-hemorrhoid suppository to the patient in sealed envelopes with a allocation concealment method, and the color and packaging of the both groups are completely similar.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Shiraz University of Medical Sciences
Street address
Central Building of Medical Sciences, Zand Street.
City
Shiraz
Province
Fars
Postal code
7134814336
Approval date
2023-12-08, 1402/09/17
Ethics committee reference number
IR.SUMS.REC.1402.430
Health conditions studied
1
Description of health condition studied
Hemorrhoid
ICD-10 code
K64
ICD-10 code description
Hemorrhoids and perianal venous thrombosis
Primary outcomes
1
Description
Pain
Timepoint
Before intervention, 2 weeks after initiation of intervention
Method of measurement
Colo-Rectal Evaluation of Clinical Therapeutics Scale questionnaire (CORECTS)
2
Description
Itching
Timepoint
Before intervention, 2 weeks after initiation of intervention
Method of measurement
Colo-Rectal Evaluation of Clinical Therapeutics Scale questionnaire (CORECTS)
3
Description
Swelling
Timepoint
Before intervention, 2 weeks after initiation of intervention
Method of measurement
Colo-Rectal Evaluation of Clinical Therapeutics Scale questionnaire (CORECTS)
4
Description
Bleeding
Timepoint
Before intervention, 2 weeks after initiation of intervention
Method of measurement
Colo-Rectal Evaluation of Clinical Therapeutics Scale questionnaire (CORECTS)
Secondary outcomes
empty
Intervention groups
1
Description
The intervention group: 28 rectal suppositories containing Commiphora mukul (Hook. Ex Stocks) Engl. and Allium porrum L. made by the researcher, BID for two weeks
Category
Treatment - Drugs
2
Description
The control group: 28 conventional anti hemorrhoid suppositories containing hydrocortisone acetate, lidocaine, aluminum sub acetate and zinc oxide, BID for two weeks
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Shahid Rahnemoun Hospital
Full name of responsible person
Abdolali Mohagheghzadeh
Street address
Farokhi Street, Shahid beheshti Square
City
Yazd
Province
Yazd
Postal code
۸۹۱۳۸۱۴۳۹۶
Phone
+98 35 3312 2002
Fax
+98 35 3312 3005
Email
rahnamoon@ssu.ac.ir
Web page address
http://web.ssu.ac.ir/
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Mohammad Hashem Hashempur
Street address
Zand
City
Shiraz
Province
Fars
Postal code
7134814336
Phone
+98 71 3230 5410
Email
info@sums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shiraz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Faculty of pharmacy
Full name of responsible person
Motahare Nayebzadeh
Position
PhD student, traditional pharmacy
Latest degree
Medical doctor
Other areas of specialty/work
Medical Pharmacy
Street address
Karafarin Street, Rokn abad Town
City
Shiraz
Province
Fars
Postal code
۷۱۴۶۸۶۴۶۸۵
Phone
+98 71 3235 5677
Email
motaharenayeb@sums.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Department of Traditional Pharmacy, School of Pharmacy
Full name of responsible person
Abdolali Mohagheghzadeh
Position
Professor of Pharmacognosy
Latest degree
Ph.D.
Other areas of specialty/work
Pharmacognosy
Street address
Karafarin Street, Rokn abad Town
City
Shiraz
Province
Fars
Postal code
۷۱۴۶۸۶۴۶۸۵
Phone
+98 71 3242 4128
Email
mohaghegh@sums.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Faculty of pharmacy
Full name of responsible person
Motahare Nayebzadeh
Position
PhD student, traditional pharmacy
Latest degree
Medical doctor
Other areas of specialty/work
Medical Pharmacy
Street address
Karafarin Street, Rokn abad Town
City
Shiraz
Province
Fars
Postal code
۷۱۴۶۸۶۴۶۸۵
Phone
+98 71 3242 4128
Email
motaharenayeb@sums.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Only a part of data like primary outcome can be shared.
When the data will become available and for how long
The access period starts 1 year after the publication time of results
To whom data/document is available
This data will be available only to researchers working in academic and scientific institutions.
Under which criteria data/document could be used
The data will be made available to researchers for further studies or more advanced analysis.
From where data/document is obtainable
Researchers can send an email regarding the request for the data of our study to Dr. Abdolali Mohagheghzadeh. Email: mohaghegh@sums.ac.ir
What processes are involved for a request to access data/document
The researchers can request for this study's data through an e-mail one year after the publication data of this study in one of the pee-reviewed journals.